Abstract

Phosphodiesterase 6 (PDE6) is a key effector enzyme in vertebrate phototransduction, and its maturation and function are known to critically depend on a specialized chaperone, aryl hydrocarbon receptor-interacting protein-like 1 (AIPL1). Defects in PDE6 and AIPL1 underlie several severe retinal diseases, including retinitis pigmentosa and Leber congenital amaurosis. Here, we characterize the complex of AIPL1 with HSP90 and demonstrate its essential role in promoting the functional conformation of nascent PDE6. Our analysis suggests that AIPL1 preferentially binds to HSP90 in the closed state with a stoichiometry of 1:2, with the tetratricopeptide repeat domain and the tetratricopeptide repeat helix 7 extension of AIPL1 being the main contributors to the AIPL1/HSP90 interface. We demonstrate that mutations of these determinants markedly diminished both the affinity of AIPL1 for HSP90 and the ability of AIPL1 to cochaperone the maturation of PDE6 in a heterologous expression system. In addition, the FK506-binding protein (FKBP) domain of AIPL1 encloses a unique prenyl-binding site that anchors AIPL1 to posttranslational lipid modifications of PDE6. A mouse model with rod PDE6 lacking farnesylation of its PDE6A subunit revealed normal expression, trafficking, and signaling of the enzyme. Furthermore, AIPL1 was unexpectedly capable of inducing the maturation of unprenylated cone PDE6C, whereas mutant AIPL1 deficient in prenyl binding competently cochaperoned prenylated PDE6C. Thus, we conclude neither sequestration of the prenyl modifications is required for PDE6 maturation to proceed, nor is the FKBP-lipid interaction involved in the conformational switch of the enzyme into the functional state.

Highlights

  • PDE6A and PDE6B subunits are farnesylated and underlie several severe retinal diseases, including geranylgeranylated, respectively, whereas retinitis pigmentosa and Leber congenital

  • Our analysis suggests that AIPL1 preferentially binds to HSP90 in the closed state with a stoichiometry of 1:2, with the tetratricopeptide repeat (TPR) domain and the TPR helix 7 extension of AIPL1 being the main contributors to the AIPL1/HSP90 interface

  • Given the ability of AIPL1-FK506-binding protein (FKBP) to bind prenyl modifications of phosphodiesterases of the 6th family (PDE6), a ternary chaperoneclient complex of HSP90/AIPL1 with nascent PDE6 can be envisioned as an intermediate in PDE6 maturation

Read more

Summary

Introduction

PDE6A and PDE6B subunits are farnesylated and underlie several severe retinal diseases, including geranylgeranylated, respectively, whereas retinitis pigmentosa and Leber congenital. The binding assay between AIPL1 and the and provided direct evidence that the HSP90/AIPL1 complex is required for closed HSP90AMPPNP state indicated a significantly higher-affinity interaction, and a maturation of PDE6. HSP90 inhibitor 17dimethylaminoethylamino-17demethoxygeldanamycin (DMAG) potently blocks expression of functional PDE6C in HEK293T cells, while AIPL1 mutations disrupting its interaction with HSP90 markedly diminish the chaperone activity of the complex.

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call